Status:
COMPLETED
SCOPE-Study: Salzburg Chronic Obstructive Pulmonary Disease- Exercise and Oxygen Study
Lead Sponsor:
Paracelsus Medical University
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
30+ years
Phase:
PHASE4
Brief Summary
Chronic obstructive pulmonary disease (COPD) is number four of the leading causes of death in the USA and Europe. Moreover, among the top five causes of death, this disease is the only one with increa...
Eligibility Criteria
Inclusion
- COPD with FEV1 pred. 30 to 60%, PO2 at rest \> 55 mmHg and PCO2 \< 45 mm Hg
- age: \> 30 years
Exclusion
- Musculoskeletal disease, which prohibits training
- Relevant neoplastic disease with cachexia
- Expected non compliance with the study protocol due to drug and alcohol abuse
- Coronary heart disease defined by angina pectoris or relevant ST-changes during exercise or myocardial infarction in the last 6 months
- Left ventricular ejection fraction \< 40 %
- Renal insufficiency with creatinine \> 2 mmol/liter
- Symptomatic intermittent claudication or peripheral neuropathy
- Anaemia \< 10 mg/dl or red blood count \< 3 Mio/mm3
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01150383
Start Date
July 1 2010
End Date
July 1 2013
Last Update
October 31 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University Salzburg
Salzburg, Austria, 5020